Clinical trial
Development and Validation of a Chinese Patient-Reported Outcome Measure for Quality of Life in Pulmonary Arterial Hypertension Patients
NCT07570615 is registered in ClinicalTrials.gov with Chinese Pulmonary Vascular Disease Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development and Validation of a Chinese Patient-Reported Outcome Measure for Quality of Life in Pulmonary Arterial Hypertension Patients
- Lead sponsor
- Chinese Pulmonary Vascular Disease Research Group
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 30, 2026
- Completion date
- April 30, 2029
- Enrollment
- 300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
patients reported outcomes, pulmonary arterial hypertension (pah), quality of life